Skip to main content
Signal8

CapForce Inc. (CFOR)

CapForce Inc. is a precision medicine company dedicated to developing and commercializing sophisticated molecular microbiology solutions. Its mission is to address life-threatening infectious diseases for patients in the United States and across international markets. The company's diverse product range includes Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel diagnostic tests, and SARS CoV-2 testing kits. Beyond its product line, CapForce extends its offerings to include laboratory services, collaboration services (such as funded software arrangements), and licensing agreements. Additionally, the company provides listing sponsorship and consultancy services. Formerly known as OpGen, Inc., the entity officially changed its name to CapForce Inc. in February 2026. CapForce Inc. was established in 2001 and maintains its headquarters in Clarksburg, Maryland.

Sector: Services-Management Consulting Services

Industry: Financial - Capital Markets

CapForce Inc. logo

CapForce Inc.

OTC:CFORFinancial Services
AH+0.00%$6.00
Close$6.00+6.19%
Mkt Cap$74.77M
EV-
Float2.42M
O/S12.46M
VOL3K sh
$ Vol$17K
RVOL1.27×
Inst Own-
SI<0.1%
Net Cash/Sh-
Dilution
CapForce Inc. logoOTC:CFORAH$6.00+0.00%